DESCRIPTION:

This talk will describe how our study of patient samples, animal models and experimental systems have elucidated the role of PPM1D in regulating blood cell development and therapy resistance in myeloid malignancies

LEARNING OBJECTIVES

  • Understand the context in which PPM1D mutations arise in patients.
  • Understand the mechanisms by which PPM1D regulates the DNA damage response and resistance to therapy.
Session date: 
11/24/2025 - 12:00pm to 1:00pm CST
Add to calendar: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Please login or create an account to proceed.
Speaker Name: 
Peter Miller, MD, PhD